Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Influenza and pneumococcal immunization in cardiovascular prevention].

Sosa Liprandi MI, Sosa Liprandi A, Fernández A, Stecher D, Bonvehí P, Verón MT.

Medicina (B Aires). 2014;74(3):245-53. Spanish.

2.

Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines.

Fiebach N, Beckett W.

Arch Intern Med. 1994 Nov 28;154(22):2545-57. Review. Erratum in: Arch Intern Med 1995 Jan 23;155(2):218.

PMID:
7979851
3.

Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.

Gilchrist SA, Nanni A, Levine O.

Am J Public Health. 2012 Apr;102(4):596-605. doi: 10.2105/AJPH.2011.300512. Epub 2012 Feb 16. Review.

4.

Factors predictive of increased influenza and pneumococcal vaccination coverage in long-term care facilities: the CMS-CDC standing orders program Project.

Bardenheier BH, Shefer A, McKibben L, Roberts H, Rhew D, Bratzler D.

J Am Med Dir Assoc. 2005 Sep-Oct;6(5):291-9.

PMID:
16165069
5.

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.

Christenson B, Hedlund J, Lundbergh P, Ortqvist A.

Eur Respir J. 2004 Mar;23(3):363-8.

6.

Influenza and pneumococcal immunization rates among a high-risk population.

Chan-Tack KM.

South Med J. 2001 Mar;94(3):323-4.

PMID:
11284519
7.

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A, Gomez F, Raga X, de Diego C, Satue E, Salsench E; EPIVAC Study Group.

BMC Public Health. 2012 Mar 22;12:222. doi: 10.1186/1471-2458-12-222.

8.

Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.

Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM.

Pharmacoeconomics. 2011 Mar;29(3):199-211. doi: 10.2165/11584930-000000000-00000. Review.

PMID:
21250759
9.

Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care.

Siriwardena AN, Rashid A, Johnson MR, Dewey ME.

Br J Gen Pract. 2002 Sep;52(482):735-40. Erratum in: Br J Gen Pract 2002 Oct;52(483):855.

10.
11.

Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Jun 29;50(25):532-7.

12.

Characteristics of long-term care facilities associated with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states.

Shefer A, McKibben L, Bardenheier B, Bratzler D, Roberts H.

J Am Med Dir Assoc. 2005 Mar-Apr;6(2):97-104.

PMID:
15871883
13.

Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).

Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW.

J Am Med Dir Assoc. 2012 Oct;13(8):698-703. doi: 10.1016/j.jamda.2012.05.009. Epub 2012 Jun 20.

PMID:
22722051
14.

Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis.

Rose DN, Schechter CB, Sacks HS.

Am J Med. 1993 Feb;94(2):160-8.

PMID:
8094271
15.

Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities.

You JH, Wong WC, Ip M, Lee NL, Ho SC.

J Epidemiol Community Health. 2009 Nov;63(11):906-11. doi: 10.1136/jech.2008.081885. Epub 2009 Jul 15.

PMID:
19608558
16.

[Pneumococcal vaccination for persons 65 years of age and older].

van den Bosch WJ.

Ned Tijdschr Geneeskd. 2002 May 4;146(18):838-9. Dutch.

PMID:
12038219
17.

Health-system pharmacists' role in immunizing adults against pneumococcal disease and influenza.

Grabenstein JD, Bonasso J.

Am J Health Syst Pharm. 1999 Sep 1;56(17 Suppl 2):S3-22; quiz S23-4.

PMID:
10512518
18.

Influenza and pneumococcal vaccination of the elderly in Taiwan.

Chen YH, Liou SH, Chou CC, Su WL, Loh CH, Lin SH.

Vaccine. 2004 Jul 29;22(21-22):2806-11.

PMID:
15246615
19.

Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Nov 5;53(43):1007-12. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Sep 23;54(37):935.

20.

Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE).

Ren S, Hure A, Peel R, D'Este C, Abhayaratna W, Tonkin A, Hopper I, Thrift AG, Levi C, Sturm J, Durrheim D, Hung J, Briffa T, Chew DP, Anderson P, Moon L, McEvoy M, Hansbro P, Newby D, Attia J; AUSPICE study group.

Am Heart J. 2016 Jul;177:58-65. doi: 10.1016/j.ahj.2016.04.003. Epub 2016 Apr 16.

PMID:
27297850

Supplemental Content

Support Center